상품명칭 |
Ginsenoside F1 |
별명 |
(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside; (2R)-6-methyl-2-[(6beta,8xi,9xi,12alpha,13alpha,14beta,17beta)-3,6,12-trihydroxy-4,4,10,14,17-pentamethylgonan-17-yl]hept-5-en-2-yl beta-D-allopyranoside; Ginsenosidef1 |
분자식 |
C36H62O9 |
분자량 |
638.8721 |
InChI |
InChI=1/C36H62O9/c1-19(2)10-9-12-36(8,45-31-28(43)27(42)26(41)24(18-37)44-31)35(7)15-14-34(6)21-16-22(38)29-32(3,4)25(40)11-13-33(29,5)20(21)17-23(39)30(34)35/h10,20-31,37-43H,9,11-18H2,1-8H3/t20?,21?,22-,23+,24-,25?,26-,27-,28-,29?,30-,31+,33-,34-,35+,36-/m1/s1 |
cas번호 |
53963-43-2 |
분자 구조 |
|
밀도 |
1.23g/cm3 |
비등점 |
752.9°C at 760 mmHg |
굴절 지수 |
1.58 |
인화점 |
409.1°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|